Cargando…

Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome

Ovarian cancer linked to Lynch syndrome represents a rare subset that typically presents at young age as early-stage tumors with an overrepresentation of endometrioid and clear cell histologies. We investigated the molecular profiles of Lynch syndrome-associated and sporadic ovarian cancer with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jönsson, Jenny-Maria, Bartuma, Katarina, Dominguez-Valentin, Mev, Harbst, Katja, Ketabi, Zohreh, Malander, Susanne, Jönsson, Mats, Carneiro, Ana, Måsbäck, Anna, Jönsson, Göran, Nilbert, Mef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231285/ https://www.ncbi.nlm.nih.gov/pubmed/24848881 http://dx.doi.org/10.1007/s10689-014-9728-1

Ejemplares similares

Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

Distinct gene expression signatures in Lynch syndrome and familial colorectal cancer type X
por: Valentin, Mev Dominguez, et al.
Publicado: (2013)

Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X
por: Dominguez-Valentin, Mev, et al.
Publicado: (2013)

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2017)

Frequent mismatch-repair defects link prostate cancer to Lynch syndrome
por: Dominguez-Valentin, Mev, et al.
Publicado: (2016)

Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival()()
por: Jönsson, Jenny-Maria, et al.
Publicado: (2015)

Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response
por: Martín de la Fuente, Laura, et al.
Publicado: (2018)

Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations
por: Bartuma, Katarina, et al.
Publicado: (2012)

Immunoprofiles of colorectal cancer from Lynch syndrome
por: Walkowska, Joanna, et al.
Publicado: (2018)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
por: Therkildsen, Christina, et al.
Publicado: (2018)

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
por: Bååth, Maria, et al.
Publicado: (2021)

Mutation spectrum in South American Lynch syndrome families
por: Dominguez-Valentin, Mev, et al.
Publicado: (2013)

Sense of coherence and self-concept in Lynch syndrome
por: Petersen, Helle Vendel, et al.
Publicado: (2013)

Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor
por: Jönsson, Mats, et al.
Publicado: (2009)

Prognostic Impact of Array-based Genomic Profiles in Esophageal Squamous Cell Cancer
por: Carneiro, Ana, et al.
Publicado: (2008)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
por: Seppälä, Toni T., et al.
Publicado: (2020)

Colorectal cancer in adolescents and young adults with Lynch syndrome: a Danish register-based study
por: Durhuus, Jon Ambæk, et al.
Publicado: (2021)

Genetic anticipation in Swedish Lynch syndrome families
por: von Salomé, Jenny, et al.
Publicado: (2017)

Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X
por: Haraldsson, Stefan, et al.
Publicado: (2017)

NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics
por: Cirenajwis, Helena, et al.
Publicado: (2017)

Focus on the Tumour Periphery in MRI Evaluation of Soft Tissue Sarcoma: Infiltrative Growth Signifies Poor Prognosis
por: Fernebro, Josefin, et al.
Publicado: (2006)

Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types
por: Therkildsen, Christina, et al.
Publicado: (2017)

CTLA-4 blockade boosts the expansion of tumor-reactive CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
por: Friese, Christina, et al.
Publicado: (2020)

Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein
por: Dominguez-Valentin, Mev, et al.
Publicado: (2014)

Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer
por: Jönsson, Jenny-Maria, et al.
Publicado: (2021)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023)

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2019)

Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity
por: Westerdahl, J, et al.
Publicado: (2000)

Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors.
por: Westerdahl, J., et al.
Publicado: (1996)

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
por: Lauss, Martin, et al.
Publicado: (2015)

Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability
por: Asp, Mihaela, et al.
Publicado: (2023)

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
por: Martin de la Fuente, Laura, et al.
Publicado: (2020)

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
por: Bååth, Maria, et al.
Publicado: (2020)

Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels
por: Domanska, Katarina, et al.
Publicado: (2009)

MLH1 Ile219Val Polymorphism in Argentinean Families with Suspected Lynch Syndrome
por: Dominguez-Valentin, Mev, et al.
Publicado: (2016)

Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72
por: Nilbert, Mef, et al.
Publicado: (2008)

Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
por: Sahin, Irem Durmaz, et al.
Publicado: (2019)

Supporter or obstructer; experiences from contact person activities among Swedish women with breast cancer
por: Carlsson, Christina, et al.
Publicado: (2005)

Patient representatives’ views on patient information in clinical cancer trials
por: Dellson, Pia, et al.
Publicado: (2016)

Ovarian carcinoma histotype in Lynch syndrome
por: Gilks, C. Blake, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lo5a2shdaqhrksmjvjge3bfa9c